Risk factor
Very poor trading liquidity
Profitability factor
Overvalued vs peers
About
BiOptic Inc. specializes as a biotechnology instrumentation firm, crafting scientific tools designed for both laboratory research and clinical applications. Their extensive product line features various instruments, including sophisticated bio-fragment analyzers and PCR thermocyclers. Additionally, they supply essential consumables such as cartridges for DNA, RNA, and protein analysis, alongside quantification kits. The company further provides specialized PCR reagents, encompassing premixed formulas and polymerases. Completing their offerings are diverse diagnostic kits tailored for veterinary, human, and food-related testing. Founded in 1993, BiOptic Inc. is headquartered in New Taipei City, Taiwan.
Company Valuation
From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITDA, r